United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 21, 2026 · Filed May 22, 2026

On May 21, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$564.11 for US$5.64M under a trading plan, leaving 18,876 shares. Filed May 22, 2026 (Form 4).

Sold
10,000 shares
Price
US$564.11 average (US$557.85 to US$566.12)
Value
US$5.64M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockOption exercise10,000US$117.7628,876Direct
May 21, 2026Common StockSale40US$557.8528,836Direct
May 21, 2026Common StockSale320US$560.0328,516Direct
May 21, 2026Common StockSale920US$562.0127,596Direct
May 21, 2026Common StockSale2,677US$563.1224,919Direct
May 21, 2026Common StockSale2,081US$564.1022,838Direct
May 21, 2026Common StockSale1,765US$565.1021,073Direct
May 21, 2026Common StockSale2,197US$566.1218,876Direct

Source

View original at SEC

Related